Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prabal K Chatterjee

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
American Journal of Nephrology|January 31, 2004
EUK-134 reduces renal dysfunction and injury caused by oxidative and nitrosative stress of the kidneyPrabal K Chatterjee, Nimesh S A Patel, Espen O Kvale, et al.
Kidney International|January 14, 2004
5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusionPrabal K Chatterjee, Bristi E Chatterjee, Helene Pedersen, et al.
Intensive Care Medicine|July 25, 2003
Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in miceSalvatore Cuzzocrea, Antonietta Rossi, Barbara Pisano, et al.
European Journal of Pharmacology|January 8, 2004
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammationSalvatore Cuzzocrea, Barbara Pisano, Laura Dugo, et al.
Critical Care Medicine|February 6, 2004
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in miceSalvatore Cuzzocrea, Barbara Pisano, Laura Dugo, et al.
Kidney International|March 13, 2003
GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injuryPrabal K Chatterjee, Nimesh S A Patel, Ahila Sivarajah, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
American Journal of Nephrology|January 31, 2004
EUK-134 reduces renal dysfunction and injury caused by oxidative and nitrosative stress of the kidneyPrabal K Chatterjee, Nimesh S A Patel, Espen O Kvale, et al.
Kidney International|January 14, 2004
5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusionPrabal K Chatterjee, Bristi E Chatterjee, Helene Pedersen, et al.
Intensive Care Medicine|July 25, 2003
Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in miceSalvatore Cuzzocrea, Antonietta Rossi, Barbara Pisano, et al.
European Journal of Pharmacology|January 8, 2004
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammationSalvatore Cuzzocrea, Barbara Pisano, Laura Dugo, et al.
Critical Care Medicine|February 6, 2004
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in miceSalvatore Cuzzocrea, Barbara Pisano, Laura Dugo, et al.
Kidney International|March 13, 2003
GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injuryPrabal K Chatterjee, Nimesh S A Patel, Ahila Sivarajah, et al.
Pageof 5